Skip to main content

Want a detailed portfolio tracker?

Rallybio (RLYB) P/E (2021 - 2026)

Rallybio (RLYB) P/E from Jul 29, 2021 to Jul 20, 2026. The TTM Rallybio (RLYB) P/E is -11.31. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Rallybio (RLYB)

YearP/EChange
2026-11.31+255.91%
2025-3.18+375.90%
2024-0.67-47.85%
2023-1.28-61.85%
2022-3.36-66.65%
2021-10.07N/A

Comparison Rallybio (RLYB) P/E with competitors

Rallybio (RLYB) P/E is -11.31.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.00-100.04%
ENLVEnlivex Ltd0.07-100.66%
FGENFibroGen Inc0.24-102.12%
CHRSCoherus Biosciences Inc0.85-107.50%
FBIOFortress Biotech Inc0.95-108.39%
ORMPOramed Pharmaceuticals Inc1.50-113.28%
AGENAgenus Inc3.01-126.60%
INVAInnoviva Inc3.15-127.88%
VXRTVaxart Inc3.55-131.37%
CRMDCorMedix Inc3.63-132.07%
CVACCureVac N.V.4.45-139.29%
GLPGGalapagos NV4.86-142.94%
SRPTSarepta Therapeutics Inc4.88-143.15%
ABEOAbeona Therapeutics Inc5.39-147.62%
ABUSArbutus Biopharma Corp5.60-149.45%
ZVRAZevra Therapeutics Inc5.89-152.03%
SPROSpero Therapeutics Inc6.23-155.05%
CGENCompugen Ltd6.31-155.80%
RIGLRigel Pharmaceuticals6.87-160.74%
SLXNSilexion Therapeutics Corp7.30-164.48%
OMEROmeros Corporation9.26-181.83%
AUPHAurinia Pharmaceuticals Inc9.58-184.71%
PLXProtalix BioTherapeutics Inc10.89-196.26%
ACADAcadia Pharmaceuticals Inc11.73-203.66%
TBPHTheravance Biopharma Inc12.26-208.37%
ADMAAdma Biologics Inc12.42-209.75%
HRMYHarmony Biosciences Holdings Inc13.82-222.14%
SABSSAB Biotherapeutics Inc14.14-224.94%
NAGENiagen Bioscience Inc14.82-230.96%
INCYIncyte Corp15.82-239.84%
REGNRegeneron Pharmaceuticals Inc15.86-240.14%
PBYIPuma Biotechnology Inc17.32-253.04%
CPRXCatalyst Pharmaceuticals Inc17.44-254.13%
EXELExelixis Inc17.54-255.00%
TGTXTG Therapeutics Inc18.97-267.62%
MDXGMimedx Group Inc20.55-281.65%
XOMAXOMA Royalty Corp22.87-302.17%
ARGXArgen X SE24.30-314.75%
CTMXCytomX Therapeutics Inc24.82-319.38%
XOMAOXOMA Royalty Corp25.34-324.01%
HALOHalozyme Therapeutics Inc25.62-326.47%
XOMAPXOMA Royalty Corp25.67-326.88%
VRTXVertex Pharmaceuticals Inc27.99-347.43%
RPRXRoyalty Pharma plc - Class A28.69-353.55%
SLNOSoleno Therapeutics Inc29.02-356.45%
ASNDAscendis Pharma A/S30.09-365.91%
LGNDLigand Pharmaceuticals Inc - Class B37.91-435.08%
APLSApellis Pharmaceuticals Inc39.02-444.88%
BMRNBiomarin Pharmaceutical Inc42.21-473.08%
KRYSKrystal Biotech Inc45.34-500.76%
ONCBeiGene Ltd69.54-714.62%
PHARPharming Group N.V.75.03-763.10%
TECHBio-Techne Corp101.96-1001.14%
VCELVericel Corp109.92-1071.52%
ALNYAlnylam Pharmaceuticals Inc117.96-1142.62%
GMABGenmab140.29-1339.94%
TLXTelix Pharmaceuticals Ltd162.15-1533.16%
CORTCorcept Therapeutics Inc212.86-1981.31%